DiaMedica Therapeutics Inc.
DMAC
$6.59
$0.050.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 43.50M | 51.33M | 59.89M | 55.32M | 30.04M |
| Total Receivables | 244.00K | 301.00K | 258.00K | 260.00K | 161.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 567.00K | 731.00K | 481.00K | 445.00K | 680.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 200.00K | 200.00K |
| Total Current Assets | 44.32M | 52.36M | 60.63M | 56.22M | 31.08M |
|
|
|||||
| Total Current Assets | 44.32M | 52.36M | 60.63M | 56.22M | 31.08M |
| Net Property, Plant & Equipment | 286.00K | 317.00K | 342.00K | 368.00K | 391.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 400.00K | 400.00K | 400.00K | 456.00K | -- |
| Total Assets | 45.00M | 53.08M | 61.37M | 57.05M | 31.47M |
|
|
|||||
| Total Accounts Payable | 2.81M | 3.29M | 1.48M | 1.92M | 1.26M |
| Total Accrued Expenses | 3.67M | 2.34M | 3.55M | 3.24M | 2.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 116.00K | 115.00K | 112.00K | 109.00K | 108.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.59M | 5.75M | 5.13M | 5.27M | 4.12M |
|
|
|||||
| Total Current Liabilities | 6.59M | 5.75M | 5.13M | 5.27M | 4.12M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 69.00K | 97.00K | 128.00K | 157.00K | 184.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.66M | 5.85M | 5.26M | 5.43M | 4.30M |
|
|
|||||
| Common Stock & APIC | 231.32M | 230.07M | 228.83M | 215.60M | 182.59M |
| Retained Earnings | -192.95M | -182.81M | -172.77M | -164.03M | -155.41M |
| Treasury Stock & Other | -37.00K | -26.00K | 50.00K | 50.00K | -14.00K |
| Total Common Equity | 38.34M | 47.24M | 56.11M | 51.62M | 27.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.34M | 47.24M | 56.11M | 51.62M | 27.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 38.34M | 47.24M | 56.11M | 51.62M | 27.17M |
|
|
|||||